Clinical trial
Monoclonal Antibody Therapy in Treating Patients With Chronic Lymphocytic…
NCT00019032 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00019032 |
|---|---|
| Title | Monoclonal Antibody Therapy in Treating Patients With Chronic Lymphocytic Leukemia |
| Official title | PHASE I STUDY OF T-CELL LARGE GRANULAR LYMPHOCYTIC LEUKEMIA USING THE MIK-BETA 1 MONOCLONAL ANTIBODY DIRECTED TOWARD THE IL-2R BETA SUBUNIT |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Leukemia |
| Intervention type | Biological |
| Interventions | monoclonal antibody Mik-beta-1 |
| Enrollment | 25 |
| Start date | Mar 1, 1996 |
| First posted | Jan 27, 2003 |
| Last update posted | Apr 28, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: